These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

260 related items for PubMed ID: 17370474

  • 1. [Cutaneous sarcoidosis during pegylated interferon alpha and ribavirin treatment of chronic hepatitis C--a case report].
    Honsová E, Sticová E, Sperl J.
    Cesk Patol; 2007 Jan; 43(1):27-30. PubMed ID: 17370474
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Probable cutaneous sarcoidosis associated with combined ribavirin and interferon-alpha therapy for chronic hepatitis C].
    Savoye G, Goria O, Herve S, Riachi G, Noblesse I, Bastien L, Courville P, Lerebours E.
    Gastroenterol Clin Biol; 2000 Jan; 24(6-7):679. PubMed ID: 10962394
    [No Abstract] [Full Text] [Related]

  • 5. Sarcoidosis associated with pegylated interferon alfa and ribavirin treatment for chronic hepatitis C: a case report and review of the literature.
    Hurst EA, Mauro T.
    Arch Dermatol; 2005 Jul; 141(7):865-8. PubMed ID: 16027302
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Sarcoidosis induced by therapy with pegylated interferon alfa-2a].
    Bruch-Gerharz D, Reifenberger J.
    Hautarzt; 2006 Apr; 57(4):317-35. PubMed ID: 16523277
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Cutaneopulmonary sarcoidosis during pegylated interferon plus ribavirin therapy].
    Sánchez-Ruano JJ, Artaza-Varasa T, Gómez-Rodríguez R, González de Frutos C, Repiso-Ortega A, Alcántara-Torres M.
    Gastroenterol Hepatol; 2006 Mar; 29(3):150. PubMed ID: 16507282
    [No Abstract] [Full Text] [Related]

  • 16. [Sarcoidosis during the treatment of hepatitis C by interferon-alpha and ribavirin: 2 cases].
    Lévêque L, de Boulard A, Bielefeld P, Sgro C, Hillon P, Gabreau T, Champigneulle B, Makki H, Besancenot JF.
    Rev Med Interne; 2001 Dec; 22(12):1248-52. PubMed ID: 11794896
    [Abstract] [Full Text] [Related]

  • 17. Interferon-induced sarcoidosis.
    Cardoso C, Freire R, Alves A, Oliveira A.
    BMJ Case Rep; 2011 Apr 19; 2011():. PubMed ID: 22696628
    [Abstract] [Full Text] [Related]

  • 18. Concurrent antiphospholipid syndrome and cutaneous [corrected] sarcoidosis due to interferon alfa and ribavirin treatment for hepatitis C.
    Shinohara MM, Davis C, Olerud J.
    J Drugs Dermatol; 2009 Sep 19; 8(9):870-2. PubMed ID: 19746680
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Facial cosmetic filler injections as possible target for systemic sarcoidosis in patients treated with interferon for chronic hepatitis C: two cases.
    Descamps V, Landry J, Francès C, Marinho E, Ratziu V, Chosidow O.
    Dermatology; 2008 Sep 19; 217(1):81-4. PubMed ID: 18446029
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.